Literature DB >> 30172758

Molecular epidemiology and clinical features of adenovirus infection in Taiwanese children, 2014.

Gu-Lung Lin1, Chun-Yi Lu2, Jong-Min Chen2, Ping-Ing Lee2, Shu-Yuan Ho3, Kuo-Chen Weng3, Li-Min Huang2, Luan-Yin Chang4.   

Abstract

BACKGROUND/PURPOSES: Human adenovirus (HAdV) infection is prevalent and has an important clinical impact on children. We aim to investigate the molecular epidemiology of HAdV infection and discover the correlations between clinical features and HAdV species in an HAdV outbreak of 2014.
METHODS: This is a retrospective study, enrolling patients under 19 years of age with HAdV infection at the National Taiwan University Hospital in 2014. We gathered the demographic and clinical data, carried out molecular typing and constructed a phylogenetic tree. Statistical analyses were performed in terms of HAdV species and hospitalization.
RESULTS: A total of 531 patients with HAdV infection were identified. HAdV-B accounted for the largest proportion (n = 387, 73%). On average, patients infected with HAdV-E were oldest, whereas those with HAdV-C infection were youngest (p < 0.001). Patients with HAdV-B (HAdV-3) infection were associated with a lower incidence of co-infection with other viruses (p < 0.001). Complications occurred in 203 (38%) patients. There were 149 (28%) patients requiring hospitalization. The risk factors for hospitalization included underlying neurological abnormalities, prematurity and the diagnosis of pneumonia. Five patients (1%) had severe HAdV infection requiring intensive care; all of them fully recovered. The phylogenetic study showed that the partial hexon genes of HAdV-1, HAdV-3, HAdV-4 and HAdV-5 remain stable over time.
CONCLUSION: We established the molecular epidemiology of HAdV infection and demonstrated the relationship between clinical features and HAdV species.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Complications; Human adenoviruses; Molecular epidemiology; Molecular typing; Pediatrics

Mesh:

Substances:

Year:  2018        PMID: 30172758     DOI: 10.1016/j.jmii.2018.07.005

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  7 in total

1.  Human adenovirus species in children with acute respiratory illnesses.

Authors:  Varvara Probst; Emily K Datyner; Zaid Haddadin; Danielle A Rankin; Lubna Hamdan; Herdi K Rahman; Andrew Spieker; Laura S Stewart; Claudia Guevara; Erin Yepsen; Jonathan E Schmitz; Natasha B Halasa
Journal:  J Clin Virol       Date:  2020-12-11       Impact factor: 3.168

Review 2.  Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.

Authors:  Su-Hsun Liu; Barbara S Hawkins; Sueko M Ng; Mark Ren; Louis Leslie; Genie Han; Irene C Kuo
Journal:  Cochrane Database Syst Rev       Date:  2022-03-03

3.  Bioinformatics analysis reveals four major hexon variants of human adenovirus type-3 (HAdV-3) as the potential strains for development of vaccine and siRNA-based therapeutics against HAdV-3 respiratory infections.

Authors:  Somnath Panda; Urmila Banik; Arun K Adhikary
Journal:  Infect Genet Evol       Date:  2020-06-23       Impact factor: 3.342

4.  Anxiety and depression due to 2019 SARS-CoV-2 among frontier healthcare workers in Kenya.

Authors:  David Onchonga; Enoch Ngetich; Wilbroda Makunda; Pius Wainaina; Diana Wangeshi; Prémusz Viktoria
Journal:  Heliyon       Date:  2021-02-23

5.  Changes of Host Immunity Mediated by IFN-γ+ CD8+ T Cells in Children with Adenovirus Pneumonia in Different Severity of Illness.

Authors:  Ruilin Zheng; Yinghua Li; Danyang Chen; Jingyao Su; Ning Han; Haitian Chen; Zhihui Ning; Misi Xiao; Mingqi Zhao; Bing Zhu
Journal:  Viruses       Date:  2021-11-28       Impact factor: 5.048

6.  Human adenoviruses in paediatric patients with respiratory tract infections in Beijing, China.

Authors:  Yiman Huang; Chao Wang; Fenlian Ma; Qiong Guo; Lihong Yao; Aijun Chen; Xiaoyi Luo; Lishu Zheng
Journal:  Virol J       Date:  2021-09-23       Impact factor: 4.099

7.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.

Authors:  Chih-Cheng Lai; Tzu-Ping Shih; Wen-Chien Ko; Hung-Jen Tang; Po-Ren Hsueh
Journal:  Int J Antimicrob Agents       Date:  2020-02-17       Impact factor: 5.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.